Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir in Kidney Transplant Recipients with Chronic HCV Infection
2014-002121-35Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2014
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of Harvoni in hepatitis C virus infection (2 arms), sponsored by Gilead Sciences. Primary endpoint: SVR12. Started Jul 2014; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2014-002121-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002121-35.